ETR/IX1 (ETR/IX1)

Deutsche Börse Xetra: ETR/IX1 · EUR

€512

+13.00 (+2.6%)· Recorded snapshot

Market cap	39.7B
Revenue (ttm)	4B
Net income (ttm)	997.5M
EPS (ttm)	€12.8
P/E (trailing)	40.1x
P/E (forward)	35.8x
Volume	44

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4B
Net income (ttm): 997.5M
EPS (ttm): €12.8
P/E (trailing): 40.1x
P/E (forward): 35.8x
Market cap: 39.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E35.8

P25 n/aP50 n/aP75 n/a

Trailing P/E40.1

P25 n/aP50 n/aP75 n/a

ROE74.2

P25 n/aP50 n/aP75 n/a

ROIC47.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ETR/IX1 indicators

Market & fundamental data

Available fields

236

Groups with data

Currency

USD

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-11-02
Employees	11,000
Employees change	0
Employees growth	0%
Enterprise value	EUR 40.5B
Exchange	Deutsche Börse Xetra
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-07-29
Fiscal year end	December
Founded	1983
Industry	Diagnostics & Research
Is primary listing	No
ISIN number	US45168D1046
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Market cap	EUR 39.7B
Next earnings date	2026-11-02
Price	EUR 512.20
Price currency	EUR
Sector	Healthcare
SIC code	2835
Stock price date	2026-10-27
Symbol	etr/IX1
Website	https://www.idexx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	53.29x
Average P/E ratio (3Y)	45.32x
Average P/E ratio (5Y)	49.9x
Earnings yield	2.49%
EV/Earnings	40.59x
EV/EBIT	30.74x
EV/EBITDA	27.14x
EV/FCF	36.88x
EV/Sales	9.91x
FCF / EV yield	2.71%
FCF yield	2.77%
Forward P/E	35.82x
Graham number	72.64767
Graham upside	-85.82%
Lynch fair value	EUR 120.80
Lynch upside	-76.42%
P/(FCF - SBC) ratio	38.06x
P/(OCF - SBC) ratio	34.65x
P/B ratio	28.11x
P/E ratio	40.1x
P/FCF ratio	36.14x
P/OCF ratio	33.06x
P/S ratio	9.96x
Price / tangible book value	41.09x
Price/EBITDA ratio	27.96x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	32.23%
EBITDA margin	35.62%
Effective tax rate	19.99%
FCF margin	26.85%
Gross margin	62.45%
Operating margin	32.23%
Pretax margin	31.28%
Profit margin	25.03%
Profit per employee	EUR 90,686
Profitable quarters	110
Profitable years	27
Revenue per employee	EUR 362,312
ROA	27.09%
ROA (5Y)	23.48%
ROCE	68.11%
ROE	74.21%
ROE (5Y)	84.36%
ROIC	47.23%
ROIC (5Y)	45.43%
SBC / revenue	1.38%
Tax / revenue	6.25%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	18.41%
EPS growth (Q)	17.63%
EPS growth (QoQ)	23.05%
EPS growth 10Y	20.49%
EPS growth 3Y	14.67%
EPS growth 5Y	11.14%
EPS growth quarters	8
EPS growth years	3
FCF growth	59.92%
FCF growth (Q)	112.68%
FCF growth (QoQ)	37.67%
FCF growth 3Y	28.38%
FCF growth 5Y	12.56%
Gross profit growth	14.43%
Gross profit growth (Q)	12.14%
Gross profit growth 3Y	10.5%
Gross profit growth 5Y	9.67%
Net income growth	15.62%
Net income growth (Q)	15.11%
Net income growth (QoQ)	21.54%
Net income growth 3Y	12.92%
Net income growth 5Y	9.38%
Net income growth quarters	8
Net income growth years	3
OCF growth	51.41%
OCF growth (Q)	86.9%
OCF growth (QoQ)	30.39%
OCF growth 10Y	16.86%
OCF growth 3Y	22.47%
OCF growth 5Y	12.23%
Operating income growth	17.77%
Operating income growth (Q)	14.08%
Operating income growth 3Y	11.88%
Operating income growth 5Y	11.18%
Revenue growth	12.77%
Revenue growth (Q)	9.66%
Revenue growth (QoQ)	6.64%
Revenue growth 10Y	10.42%
Revenue growth 3Y	9.02%
Revenue growth 5Y	8.37%
Revenue growth quarters	46
Revenue growth years	28

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -102.6M
Depreciation and amortization	EUR 138.4M
EBIT	EUR 1.3B
EBITDA	EUR 1.4B
EPS	EUR 12.77
Financing cash flow	EUR -1.1B
Free cash flow	EUR 1.1B
Free cash flow minus SBC	EUR 1B
Gross profit	EUR 2.5B
Income taxes	EUR 249.3M
Investing cash flow	EUR -115.6M
Net borrowing	EUR -121.2M
Net cash flow	EUR 28.3M
Net income	EUR 997.5M
Operating cash flow minus SBC	EUR 1.1B
Operating income	EUR 1.3B
Revenue	EUR 4B
Stock-based compensation	EUR 55.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	21.94
Book value per share	EUR 17.90
Debt / EBITDA	0.66
Debt / equity	0.68
Debt / FCF	0.87
Goodwill	EUR 369.1M
Interest coverage	38.84
Long-term assets	EUR 1.7B
Long-term liabilities	EUR 445.1M
Net cash (debt)	EUR -787M
Net cash / market cap	-1.98%
Net debt / EBITDA	0.55
Net debt / equity	0.56
Net debt / FCF	0.72
Piotroski F-Score	8
Property, plant and equipment	EUR 768.8M
Shareholders' equity	EUR 1.4B
Tangible book value	EUR 965.9M
Tangible book value per share	EUR 12.25
Total assets	EUR 3B
Total cash	EUR 172.4M
Total debt	EUR 959.4M
Total liabilities	EUR 1.6B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.34
Current assets	EUR 1.4B
Current liabilities	EUR 1.2B
Current ratio	1.17
Inventory turnover	4.36
Net working capital	EUR 630.7M
Quick ratio	0.73
Working capital	EUR 194.2M
Working capital turnover	22.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.4%
Shareholder yield	2.4%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 506.32
1D price change	2.6%
1M price change	12.82%
1M total return	12.82%
1W price change	2.98%
1W total return	2.98%
1Y price change	-7.91%
1Y return CAGR	-7.92%
1Y total return	-7.91%
20-day SMA	EUR 478.69
200-day SMA	EUR 528.85
3M price change	7.13%
3M total return	7.13%
3Y price change	28.73%
3Y return CAGR	8.78%
3Y total return	28.73%
50-day SMA	EUR 471.16
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 663.20
52-week high date	2025-11-27
52-week low	EUR 431.80
52-week low date	2026-09-10
5Y price change	-9.28%
5Y return CAGR	-1.93%
5Y total return	-9.28%
6M price change	2.28%
6M total return	2.28%
All-time high	EUR 663.20
All-time high date	2025-11-27
All-time low	EUR 309.40
All-time low date	2022-06-16
Average true range (ATR)	EUR 8.13
Average volume	11
Change from 52-week high	-22.77%
Change from 52-week low	18.62%
Change from all-time high	-22.77%
Change from all-time low	65.55%
Change from open	0.23%
Day's gap	2.36%
Dollar volume	EUR 22,537
High price	EUR 515.00
Low price	EUR 511.00
Monthly RSI	53.12
Open price	EUR 511.00
Position in 52-week range	30%
Previous close	EUR 499.20
Price vs 150-day SMA	1.16%
Price vs 20-day SMA	7%
Price vs 200-day SMA	-3.15%
Price vs 50-day SMA	8.71%
Relative volume	4.02
RSI	71.51
Sharpe ratio	0.49
Sharpe ratio (3Y)	0.43
Sortino ratio	1.19
Sortino ratio (3Y)	0.94
Volume	44
Weekly RSI	53.41
YTD price change	-9.95%
YTD total return	-9.95%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	78.5M
Shares change (QoQ)	-1.06%
Shares change (YoY)	-2.4%
Shares held by insiders	0.26%
Shares held by institutions	96.67%
Short ratio	3.5 days

Deeper analysis on ETR/IX1

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ETR/IX1 report

Is a complete ETR/IX1 research report available?

No complete published report is available for etr/IX1 (ETR/IX1) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ETR/IX1 (ETR/IX1)

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/IX1

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/IX1 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ETR/IX1

Frequently asked questions